Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
Cancer Cell Int
.
2020 Oct 28:20:521.
doi: 10.1186/s12935-020-01609-w.
eCollection 2020.
Authors
Seyed Mohammad Miri
1
,
Elham Tafsiri
2
,
William Chi Shing Cho
3
,
Amir Ghaemi
1
Affiliations
1
Department of Virology, Pasteur Institute of Iran, Tehran, Iran.
2
Molecular Medicine Department, Pasteur Institute of Iran, Biotechnology Research Center, Tehran, Iran.
3
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.
PMID:
33132758
PMCID:
PMC7594476
DOI:
10.1186/s12935-020-01609-w
Abstract
[This corrects the article DOI: 10.1186/s12935-020-01546-8.].
© The Author(s) 2020.
Publication types
Published Erratum